Handelsavisen
prelaunch
Companies ›Healthcare ›EDX.ASE
ED
EDX.ASE — — Healthcare Facilities & Services

Edx Medical Group PLC

$10,95
Open in Charts → Attach watcher ⌖
— —
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
—
P/E
—
EV / Rev
—
Div yield
—
Op margin
-3 466,5 %
ROE
-129,6 %
Net margin
-2 931,6 %
Debt / equity
0,05
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
—
Open
—
Next earnings
—
Ex-dividend
—
TR 1Y
—
About

EDX.ASE operates in the healthcare sector, primarily engaged in pharmaceuticals, and generates revenue through the provision of healthcare services and equipment.

Business. EDX.ASE is a healthcare company operating within the Healthcare Facilities & Services industry, with primary activities in pharmaceuticals. The firm generates revenue through service-based models typical of the healthcare services and equipment sector. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not available in the provided data. Consequently, the company is described at the industry level without geographic or segment-specific breakdowns.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityPharmaceuticals
Generated · model-assisted
Sell-side consensus
—consensus pending
— buy— hold— sell
Avg 12m price target—
Upcoming events
— missing data
See all catalysts →

At a glance

Score
—
not yet scored
Valuation
—
valuation pending
Analysts
—
not yet wired
Ownership
—
not yet wired
Profitability→
-129,6 %
return on equity
Quality
—
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning EDX.

    • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to EDX.ASE. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    EDX.ASE is a healthcare company operating within the Healthcare Facilities & Services industry, with primary activities in pharmaceuticals. The firm generates revenue through service-based models typical of the healthcare services and equipment sector. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not available in the provided data. Consequently, the company is described at the industry level without geographic or segment-specific breakdowns.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityPharmaceuticals
    AI synthesis
    GENERATED

    EDX.ASE exhibits a strong liquidity position, with a current ratio of 3.32, indicating the company can cover its short-term liabilities more than three times over. The company holds GBP 2,402,630 in cash and equivalents, which is a significant portion of its total assets of GBP 3,738,060. However, the company's operating cash flow is negative at GBP -3,468,040, and its free cash flow is also negative at GBP -3,512,300, suggesting operational inefficiencies or high capital expenditures.

    Profitability metrics for EDX.ASE are concerning, with a return on equity of -1.2958 and a return on assets of -0.9616. These figures indicate that the company is not generating returns for its shareholders or effectively utilizing its assets. The operating income is significantly negative at GBP -4,250,240, and the net income is also negative at GBP -3,594,390, highlighting the company's financial distress.

    The company's revenue is GBP 122,610, and there is no detailed breakdown of segments or geographic exposure provided in the available data. This lack of information makes it difficult to assess the concentration of revenue across different business lines or regions.

    The growth trajectory of EDX.ASE is not clearly defined due to the absence of historical revenue data and future outlook projections. The company's negative operating and net income suggest a challenging financial environment, and without specific growth initiatives or strategic plans, the company may struggle to improve its financial position.

    Risk factors for EDX.ASE include low liquidity and the potential for dilution, although no immediate filing-based liquidity or dilution flags were detected. The company's negative cash flows and operating losses may necessitate additional financing, which could lead to equity dilution. However, the risk of dilution is currently assessed as low.

    Recent events and filings for EDX.ASE do not provide specific details, but the company's financial snapshot indicates ongoing operational challenges. The absence of recent significant events or strategic announcements suggests a lack of immediate action to address the company's financial issues.

    Key takeaways
    • EDX.ASE has a strong liquidity position with a current ratio of 3.32 and significant cash reserves.
    • The company is experiencing significant financial distress, with negative operating and net income.
    • Profitability metrics such as return on equity and return on assets are negative, indicating poor performance.
    • There is no detailed information on revenue concentration or geographic exposure.
    • The risk of dilution is currently low, but the company's negative cash flows may necessitate additional financing.
    • Recent events and filings do not provide specific details on strategic initiatives to address financial challenges.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $10,95
    Market cap
    —
    Enterprise valueⓘ
    —
    P/Eⓘ
    —
    Non-GAAP P/Eⓘ
    —
    EV / Revenueⓘ
    —
    EV / Op incomeⓘ
    —
    EV / OCFⓘ
    —
    P / Bⓘ
    —
    P / Tangible bookⓘ
    —
    Tangible book
    $2.8M
    Net cashⓘ
    $2.3M
    Current ratioⓘ
    3.3
    Debt / equityⓘ
    0.1
    ROAⓘ
    -96.2%
    ROEⓘ
    -1.3%
    Cash conversionⓘ
    96.0%
    CapEx / revenueⓘ
    -1.7%
    SBC / revenueⓘ
    —
    Dilution ratioⓘ
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin-3 466,5 %Bottom quartile
    Net Margin-2 931,6 %Bottom quartile
    ROE-129,6 %Bottom quartile
    Capex / Rev-166,6 %Bottom quartile
    D/E0,05Above P75
    Cash Conv0,96Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • EDX.ASE Market data — financials · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    EDX.ASECanonical
    — · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage